YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[short sale] abluecup As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of shares outstandi…
[Scientists inside a laboratory] Hinterhaus Productions The Food and Drug Administration and Duke-Margolis Institute for Health Policy will convene a public workshop this month to examine one of the most difficult questions in rare disease…
[short sale] abluecup As September begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 44 stocks with short interest above 20% of shares outstan…
SELLAS Life Sciences Group, Inc. - Three posters to highlight preclinical activity of SLS009 (tambiciclib) across patient-derived KRAS mutant organoid models of pancreatic cancer – - Studies conducted in collaboration with the University o…
Medical lab microscope chemistry biology test by Shutter2U via Adobe Stock The biotechnology sector has long rewarded companies that can translate early clinical promise into late-stage validation, and nowhere is that dynamic more pronounc…
Sellas Life Sciences (NASDAQ:SLS) saw its share price decline by 13.15 percent on Friday to close at $13.21 apiece, as investors turned increasingly concerned about the company's silence about its treatment candidate for acute myeloid leuk…
Options button on browser by Pashalgnatov via iStock Yesterday's markets weren't good. All three major indexes lost ground on the day—the Dow lost 2.19%, the S&P 500 was down 1.52%, and the Nasdaq Composite was off 1.74%—as investors worri…
Sellas Life Sciences bounced back by 12.26 percent on Friday to close at $13.19 apiece, as investors positioned portfolios ahead of a potentially company-defining clinical data release, supported by takeover speculations and growing instit…
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SELLAS Life Sciences Group Inc (Symbol: SLS), where a total of 127,145 contracts have traded so far, representing approximately 12…
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) is one of the 10 Best Performing American Stocks in June 2026. On July 6, 2026, Alliance Global analyst James Molloy raised the firm's price target on SELLAS Life Sciences Group, Inc. (NASDAQ:S…
3d illustration inflation and deflation graph by Deepadesigns via Shutterstock SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all produc…
(RTTNews) - Today's top gainers include SL Science, which was recently listed on the Nasdaq; Chemomab, gearing up for a Phase 3 trial in primary sclerosing cholangitis; Propanc, following the launch of a share repurchase program; and Tecto…
Check out the companies making the biggest moves in the premarket: AeroVironment — The drone maker rallied 30% after reporting an earnings and revenue beat. AeroVironment earned $1.84 per share on revenue of $642 million . Analysts polled…
(RTTNews) - Today's top gainers include Universe Pharma, which expanded its pharmaceutical patent portfolio; Decoy Therapeutics, following the announcement of a PIPE financing; QuidelOrtho, on reports that it is exploring the sale of one o…
Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch's Substack. In this article, we will summarize the bulls' thesis on SLS. SELLAS Life Sciences Group, Inc.'s share was tradin…
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the 9 Stocks Winning by Double Digits. Sellas Life Sciences extended its winning streak to a 6th straight session on Thursday, climbing 14.83 percent to end at $10.53 apiece, following…
(RTTNews) - Today's top gainers in the biotech space include Bio-Techne, following acquisition news; Satellos Bioscience, gearing up to present new DMD data next month; and Kymera, which has revised its clinical data readout timeline, amon…
We just covered the 10 Stocks That Will 10X According to Social Media. Sellas Life Sciences (NASDAQ:SLS) ranks #10 (see 5 Stocks That Will 10X According to Social Media). Number of Hedge Fund Investors: 13 Sellas Life Sciences (NASDAQ:SLS)…
The United States market remained flat over the last week but has shown a strong performance with a 24% increase over the past year, and earnings are forecast to grow by 19% annually. In this context, identifying high growth tech stocks in…
[Financial market sector Healthcare on blue finance background from graphs, charts. 3D render] Vladimir Zakharov A screen of U.S. healthcare stocks with market capitalizations between $300M and $2B highlights several small-cap companies, i…
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) was one of the stocks on Jim Cramer’s radar on Mad Money as he explained that many investors might be missing out on the market’s biggest winners. Responding to a caller’s question about the co…
(RTTNews) - In today's gainers' list, we cover HCW Biologics, its upcoming catalysts and going concern risks; Silexion's development progress of its lead drug candidate SIL204; Immunovant's encouraging rheumatoid arthritis data; why invest…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Solaris Resources (TSX:SLS) is back in focus after securing Environmental Impact Assessment approval in Ecuador and addition…
Over the last 7 days, the United States market has remained flat, yet it is up 25% over the past year with earnings expected to grow by 17% annually in the coming years. In this context of robust growth and stability, identifying high-grow…
U.S. stocks were mixed, with the Nasdaq Composite gaining more than 100 points on Wednesday. Shares of Vishay Intertechnology Inc(NYSE:VSH) rose sharply after the company reported better-than-expected first-quarter financial results and is…
Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26% t…
Shares of Nextpower Inc(NASDAQ:NXT) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and raised its FY27 sales guidance. The company announced it will acquire assets of Zig…
VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — The world needs copper faster than it can find it. Latin America's mining sector is pulling in record investment as analysts project a 10 mi…
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the best healthcare penny stocks to buy according to hedge funds. On March 19, Chief Executive Officer Angelos Stergiou reiterated that 2026 is poised to be a pivotal year for Sellas L…
Solaris Resources HIGHLIGHTS OF THE PRESS RELEASE: EIA Technical Approval Received – Major permitting milestone achieved following a comprehensive multi-year government review, significantly de-risking the Warintza Project US$50 million Fi…
- Getty Images/iStockphoto Certain stocks are good bets to lag the market in the coming months, according to a new study, regardless of what the market does. Sixteen of these stocks are listed in a table at the end of this column. Short se…
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is one of the popular penny stocks on Robinhood to buy. On March 17, SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) announced that it will present preclinical data on SLS009 at the American Assoc…
(RTTNews) - SELLAS Life Sciences Group, Inc. (SLS), a late-stage clinical biopharmaceutical company, reported financial results for the full year 2025, reflecting a narrower net loss and provided a clinical pipeline update. For 2025, net l…
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of ca…
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – Biopharma M&A is entering a fever pitch, with precision oncology investments alone exploding to…
The most-talked-about stocks in the Reddit subforum Wallstreetbets were advancing hours before Monda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…